Physician profile
Brian C Cox
NPI 1215034111
$4,017.72
in general payments reported to CMS, 2019-2025
44 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $200 · 2021: $687 · 2022: $600 · 2023: $923 · 2024: $720 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,005.71 | 2019-2024 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $341.88 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $222.53 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $214.72 | 2019-2024 | |
| Pfizer INC. | $140.45 | 2019-2022 | |
| Boston Scientific Corporation | $139.94 | 2019-2025 | Rezum Generator, Obtryx System - Curved |
| Myriad Genetic Laboratories, INC. | $123.55 | 2022-2024 | Prolaris |
| Teleflex LLC | $121.29 | 2023 | Urolift |
| Dornier Medtech America, INC | $109.11 | 2025 | Dornier Medtech |
| Accord Healthcare, INC. | $107.81 | 2024 | |
| Coloplast Corp | $107.63 | 2021-2024 | Altis |
| Myovant Sciences INC. | $107.20 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $99.04 | 2019-2022 | |
| Axonics, INC. | $83.73 | 2023-2024 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $81.08 | 2021-2024 | Jelmyto |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.